Moderna, after losing US funding, rebounds to start mRNA bird flu vaccine trial
BioPharma Dive
A program that got caught up in HHS decision to abandon mRNA research was revived by a public-private coalition and is now beginning a large, late-stage test that could support a future approval.
pharminent
April 22, 2026 (Last updated: April 22, 2026)
BioPharma Dive
A program that got caught up in HHS decision to abandon mRNA research was revived by a public-private coalition and is now beginning a large, late-stage test that could support a future approval.
